Binay Shah, MD

Shah

Dr. Binay Shah is a board certified oncologist and hematologist at PeaceHealth United General Hospital, Sedro Woolley, WA. Dr. Shah is a well published researcher who has published and presented over 125 papers in various journals and meetings. His research focus is health outcomes and health disparities among cancer patients. He is invited nationally and internationally to speak on various cancers and global health. He has the distinction of developing the nation’s first statewide personalized cancer care tumor board as president of the Idaho Society of Clinical Oncology.

A passionate philanthropist and a patient advocate, Dr. Shah established the Binaytara Foundation about a decade ago with the goal of improving healthcare in resource poor communities and improving cancer care worldwide. He received the 2016 Sweeny Spirit of Medicine Award from the University of Illinois College of Medicine for his humanitarian efforts.


Aju Mathew, MD, MPhil, FACP
Picture5Dr. Aju Mathew is an assistant professor in medical oncology and an attending physician at the University of Kentucky Markey Cancer Center. Is is also the co-director of the hematology/medical oncology fellowship program. Dr. Mathew’s research focuses on global oncology, as well as breast and gastro-intestinal malignancies. He serves as the director of Kerala Cancer Care, a non-governmental organization that aims to reduce cancer disparities in India.

 

 

 

 

 


Gilberto de Lima Lopes Junior, MD, MBA, FAMS

Picture6

Dr. Gilberto Lopes, a medical oncologist, is the medical director for international programs and associate director for Global Oncology at the University of Miami Sylvester Comprehensive Cancer Center and associate professor at the Miller School of Medicine; and associate editor for ASCO University and for the society’s Journal of Global Oncology; he previously worked at the Johns Hopkins University and was chief medical and scientific officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr. Lopes has published more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, Nature Reviews, Lancet, Lancet Oncology and Health Affairs. In addition to delivering lectures around the world, he has been principal, co-Principal Investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary and thoracic cancers. His other main areas of research interest are health economics, value, policy and access to cancer drugs and treatment in low and middle income countries.

Dr. Lopes is currently a committee member for the International Association for the Study of Lung Cancer (IASLC), a member of the European Society of Medical Oncology expensive, innovative Medicines working group and the chair for the international clinical trials workshop working group and track leader for global health at the American Society of Clinical Oncology (ASCO), as well as an executive board member for the Latin American Cooperative Oncology Group (LACOG).

He has also served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization and advised governments, professional societies and industry on issues related to cancer control and treatment in low- and middle-income countries.


Renato Martins, MD, MPH

Martins

Dr. Renato Martins is a Professor of Medicine, and holds the Stephen H. Petersdorf Endowed Chair in Cancer Care, at the University of Washington. He is currently the Associate Medical Director of Solid Tumor Adult Oncology, and the Clinical Research Director of the Thoracic and Head and Neck Oncology Program at the Seattle Cancer Care Alliance, as well as a Full Member of the Fred Hutchinson Cancer Research Center.  After completing medical school in Rio, Brazil, Dr. Martins came to the United States for further training. He completed his fellowship in hematology/oncology at Massachusetts General Hospital and Harvard Medical School while also earning a Master degree in Public Health at Harvard. Dr. Martins has been with the FHCRC/SCCA/University of Washington since 2004. His research interests are in the area of immunotherapy, targeted therapies for lung cancer and value in oncology care.

 


Damiano Rondelli, MD

Rondelli

Dr. Damiano Rondelli is a Professor of Medicine and Director of Stem Cell Transplant Program at the University of Illinois at Chicago. His clinical research focuses on allogeneic stem cell transplantation. In particular, his interest has been on the use of i.v. busulfan in transplant conditioning regimens, stem cell transplantation in myelofibrosis and identification of biomarkers of acute and chronic GVHD by flow cytometry. His laboratory focuses on in-vitro and in-vivo models of T cell alloreactivity against hematopoietic stem cells and translational strategies to overcome it.

Dr. Rondelli serves as a member of the International Myeloproliferative Disorders Research Consortium (MPD-RC), funded by an NCI PO1 grant (PI Ronald Hoffman, MD) where he chairs a study using a reduced intensity conditioning regimen in allogeneic stem cell transplantation for patients with myelofibrosis.

Dr. Rondelli has published over 90 full-papers in international peer-reviewed journals including Blood, Leukemia, Biology Blood Marrow Transplantation, and is a co-author of an Italian Hematology textbook. “Lezioni di Ematologia” by Sante Tura et al, Esculapio Bologna, 2003. He is a reviewer of many esteemed journals including Blood, Cancer research, American Journal of Transplantation, etc.

Dr. Rondelli received his medical degree with honors from the University of Bologna, Italy. After completing School of specialization in hematology at the University of Bologna, he worked as research associate at the Fred Hutchinson Cancer Research Center, Seattle, WA where he started his studies on the antigen presenting function of CD34+ hematopoetic stem cells.


Timothy Erickson, MD, FACEP, FACMT, FAACT

Erickson

Dr. Timothy B. Erickson is an emergency medicine physician at the Brigham and Women’s Hospital in Boston, MA, USA where he serves as the Chief of Medical Toxicology in the Department of Emergency Medicine. He is also a teaching faculty member at Harvard Medical School. Dr. Erickson is also a core faculty member at the Harvard Humanitarian Initiative (HHI) in Cambridge, MA with expertise in environmental toxicology and crisis in climate change. He has active humanitarian health projects in Nepal and India as well as in conflict regions of Ukraine and Syria.

Dr. Erickson earned his M.D. degree from The Chicago Medical School in 1986. He completed emergency medicine residency training at the University of Illinois and his medical toxicology fellowship at Cook County Hospital in Chicago. Dr. Erickson is a Fellow of the American College of Emergency Physicians, American College of Medical Toxicology, American Academy of Clinical Toxicology, and the prestigious National Geographic Explorers Club.

Previously, Dr. Erickson served as the Director for the UIC Center for Global Health and Full Professor of Emergency Medicine and Medical Toxicology at the University of Illinois at Chicago. Dr. Erickson also served as the Associate Dean for Faculty Affairs, Graduate Medical Education, and Continuing Medical Education at the UIC College of Medicine. He was an Acting and Interim Head in the Department of Emergency Medicine and has held other multifaceted appointments ranging from EM Residency Program Director to Chief of Medical Toxicology.

Dr. Erickson has been a member of multiple editorial boards and has an active academic history including publishing over 120 original journal articles and book chapters as well as editing 4 major textbooks. He has presented over 100 national and international invited lectures related to emergency medicine, toxicology, humanitarian global health, and wilderness/expedition medicine.

Dr. Erickson’s federal grant funding includes HRSA sponsored grants related to global preparedness and bioterrorism and a Medtronic foundation grant addressing acute cardiovascular disease in India. He has extensive international experience in Africa (Rwanda, Sudan, Kenya), Asia (India, Vietnam, Nepal), South America (Brazil, Peru, Argentina), Europe (Kosovo, Ukraine, France) and Antarctica.


Shailender Bhatia, MD

Bhatia

Bio coming soon.

 

 

 

 

 

 

 


Others coming soon…………..